These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29587287)

  • 1. Cohesin RAD21 Gene Promoter Methylation in Patients with Chronic Lymphocytic Leukemia.
    Ioannidou A; Zachaki S; Karakosta M; Daraki A; Roussou P; Manola KN
    Cytogenet Genome Res; 2018; 154(3):126-131. PubMed ID: 29587287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
    Wang LQ; Wong KY; Li ZH; Chim CS
    Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
    Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
    Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia.
    Papageorgiou SG; Lambropoulos S; Pappa V; Economopoulou C; Kontsioti F; Papageorgiou E; Tsirigotis P; Dervenoulas J; Economopoulos T
    Am J Hematol; 2007 Sep; 82(9):824-5. PubMed ID: 17546638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic profile in chronic lymphocytic leukemia using methylation-specific multiplex ligation-dependent probe amplification.
    Cosialls AM; Santidrián AF; Coll-Mulet L; Iglesias-Serret D; González-Gironès DM; Pérez-Perarnau A; Rubio-Patiño C; González-Barca E; Alonso E; Pons G; Gil J
    Epigenomics; 2012 Oct; 4(5):491-501. PubMed ID: 23130831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia.
    Martinelli S; Kanduri M; Maffei R; Fiorcari S; Bulgarelli J; Marasca R; Rosenquist R
    Epigenetics; 2013 Jul; 8(7):720-9. PubMed ID: 23803577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncovering the DNA methylome in chronic lymphocytic leukemia.
    Cahill N; Rosenquist R
    Epigenetics; 2013 Feb; 8(2):138-48. PubMed ID: 23321535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets.
    Rush LJ; Raval A; Funchain P; Johnson AJ; Smith L; Lucas DM; Bembea M; Liu TH; Heerema NA; Rassenti L; Liyanarachchi S; Davuluri R; Byrd JC; Plass C
    Cancer Res; 2004 Apr; 64(7):2424-33. PubMed ID: 15059895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
    Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
    Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLL.
    Schmidt-Wolf IG; Plass C; Byrd JC; Frevel K; Pietsch T; Waha A
    Anticancer Res; 2016 Sep; 36(9):4515-9. PubMed ID: 27630290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant Methylation of Tumour Suppressor Gene ADAM12 in Chronic Lympocytic Leukemia Patients: Application of Methylation Specific-PCR Technique.
    Mohamad A; Hassan R; Husin A; Johan MF; Sulong S
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):85-91. PubMed ID: 33507683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.
    Mansouri L; Wierzbinska JA; Plass C; Rosenquist R
    Semin Cancer Biol; 2018 Aug; 51():1-11. PubMed ID: 29427646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia.
    Ronchetti D; Tuana G; Rinaldi A; Agnelli L; Cutrona G; Mosca L; Fabris S; Matis S; Colombo M; Gentile M; Recchia AG; Kwee I; Bertoni F; Morabito F; Ferrarini M; Neri A
    Genes Chromosomes Cancer; 2014 Mar; 53(3):264-73. PubMed ID: 24347044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia.
    Raval A; Lucas DM; Matkovic JJ; Bennett KL; Liyanarachchi S; Young DC; Rassenti L; Kipps TJ; Grever MR; Byrd JC; Plass C
    J Clin Oncol; 2005 Jun; 23(17):3877-85. PubMed ID: 15809452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia.
    Oakes CC; Seifert M; Assenov Y; Gu L; Przekopowitz M; Ruppert AS; Wang Q; Imbusch CD; Serva A; Koser SD; Brocks D; Lipka DB; Bogatyrova O; Weichenhan D; Brors B; Rassenti L; Kipps TJ; Mertens D; Zapatka M; Lichter P; Döhner H; Küppers R; Zenz T; Stilgenbauer S; Byrd JC; Plass C
    Nat Genet; 2016 Mar; 48(3):253-64. PubMed ID: 26780610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia.
    Pei L; Choi JH; Liu J; Lee EJ; McCarthy B; Wilson JM; Speir E; Awan F; Tae H; Arthur G; Schnabel JL; Taylor KH; Wang X; Xu D; Ding HF; Munn DH; Caldwell C; Shi H
    Epigenetics; 2012 Jun; 7(6):567-78. PubMed ID: 22534504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia.
    Hanoun M; Eisele L; Suzuki M; Greally JM; Hüttmann A; Aydin S; Scholtysik R; Klein-Hitpass L; Dührsen U; Dürig J
    PLoS One; 2012; 7(3):e34347. PubMed ID: 22470559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia.
    Tsirigotis P; Pappa V; Labropoulos S; Papageorgiou S; Kontsioti F; Dervenoulas J; Papageorgiou E; Panani A; Mantzios G; Economopoulos T; Raptis S
    Eur J Haematol; 2006 Mar; 76(3):230-6. PubMed ID: 16412137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus.
    Frenzel LP; Claus R; Plume N; Schwamb J; Konermann C; Pallasch CP; Claasen J; Brinker R; Wollnik B; Plass C; Wendtner CM
    Int J Cancer; 2011 May; 128(10):2495-500. PubMed ID: 20669229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation status regulates lipoprotein lipase expression in chronic lymphocytic leukemia.
    Abreu C; Moreno P; Palacios F; Borge M; Morande P; Landoni AI; Gabus R; Dighiero G; Giordano M; Gamberale R; Oppezzo P
    Leuk Lymphoma; 2013 Aug; 54(8):1844-8. PubMed ID: 23614796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.